DiaMedica Therapeutics Q1 EPS $(0.18), Inline
Benzinga Newsdesk 1 year ago
EarningsNews
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a 28.57 percent decrease over losses of $(0.14) per share from the same period last
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a 28.57 percent decrease over losses of $(0.14) per share from the same period last year.